<
>
Retatrutide (2381089-83-2)
Product Summary
Retatrutide is a potent triple agonist targeting GLP-1, GIP, and GCGR for advanced weight loss and metabolic therapy. Offers superior efficacy over dual agonists like tirzepatide. For R&D use only.
Product Custom Attributes
Product Description
Retatrutide is an innovative, investigational triple agonist peptide that targets three key metabolic pathways: GLP‑1, GIP, and GCGR (glucagon receptor). Designed to deliver more potent weight loss and metabolic improvement than earlier dual agonists like tirzepatide, it represents a major advance in chronic weight management and metabolic disorder therapy.
*The product under patent is only for R&D use.
Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.
